Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q4 FY25 Earnings Presentation
24 slides from Valiant Organics's earnings presentation, May 30, 2025
Slide 1: Cover letter to stock exchanges: Investors Presentation
May 30, 2025 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, Dalal Street G Block Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E), Mumbai- 400 051. SCRIP CODE – 540145 SY
Slide 2: Earnings Presentation | Q4-FY25/FY25
Earnings Presentation | Q4 -FY25/FY25
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries And Product Basket
Chemistries And Product Basket FY25 Revenue Share Hydrogenation Ammonolysis 47% Key Products: Industries Served: Key Products: • Ortho Anisidine Industries Served: • Dyes • Para Nitro Aniline • Para Anisidine • Dyes • Pigments • Ortho Chloro Para Nitro Aniline • IPPCA • Pigments • Pharmaceutical • M
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 27,000 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Q4-FY25/FY25 Highlights
Q4-FY25 /FY25 HIGHLIGHTS Valiant Organics Limited | Q4-2025 7
Slide 9: Consolidated Financial Highlights
CONSOLIDATED FINANCIAL HIGHLIGHTS Q4-FY25 CONSOLIDATED FINANCIAL HIGHLIGHTS FY25 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 2,038 Mn INR 7,188 Mn Operational Revenue Operational Revenue INR 203 Mn INR 537 Mn Operating EBITDA Operating EBITDA 9.96 % 7.47 % Operating EBITDA Margin Operating EBITDA Margin I
Slide 10: Q4-FY25/FY25 Operational Highlights
Q4-FY25/FY25 Operational Highlights • The company reported INR 2,038 millions in revenue for Q4 FY25, reflecting a Q4-FY25 Revenue Break-up – Chemistries 15% year on year growth. This performance was driven by higher volumes and Others, 2% improved realizations across key product segments. • Gross P
Slide 11: Revenues and Sales Volumes by Key Chemistries
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1200 1,126 700 120 413 582 97 879 420 1000 513 REVENUES 600 100 410 458 73 800 668 500 80 400 400 600 60 390 42 380 300 379 400 40 380 200 200 20 370 100 0 0 360 0 Q4-FY24 Q3-FY25 Q4-FY25 Q4-FY24 Q3-FY2
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q4-FY25 Q4-FY24 Y-o-Y Q3-FY25 Q-o-Q Revenue from Operations 2,038 1,768 15.3% 1,869 9.0% Total Expenses 1,835 1,786 2.7% 1,715 7.0% EBITDA 203 (18) NA 154 31.8% EBITDA Margins (%) 9.96% (1.02)% NA 8.24% 172 bps Other Income 7 21 (66.7
Slide 13: Annual Consolidated Financial Performance
Annual Consolidated Financial Performance Particulars (INR Mn) FY25 FY24 Y-o-Y Revenue from Operations 7,188 7,231 (0.6)% Total Expenses 6,651 6,849 (2.9)% EBITDA 537 382 40.6% EBITDA Margins (%) 7.47% 5.28% 219 bps Other Income 86 93 (7.5)% Depreciation 358 349 2.6% Finance Cost 236 163 44.8% PBT (
Slide 14: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q4-FY25 Q4-FY24 Y-o-Y Q3-FY25 Q-o-Q Revenue from Operations 2,038 1,768 15.3% 1,869 9.0% Total Expenses 1,835 1,786 2.7% 1,715 7.0% EBITDA 203 (18) NA 154 31.8% EBITDA Margins (%) 9.96% (1.02)% NA 8.24% 172 bps Other Income 7 21 (66.7)%
Slide 15: Annual Standalone Financial Performance
Annual Standalone Financial Performance Particulars (INR Mn) FY25 FY24 Y-o-Y Revenue from Operations 7,188 6,772 6.1% Total Expenses 6,651 6,376 4.3% EBITDA 537 396 35.6% EBITDA Margins (%) 7.47% 5.85% 162 bps Other Income 81 29 NA Depreciation 358 340 5.3% Finance Cost 236 194 21.6% PBT (Excl. Exce
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | Q4-2025 15
Slide 17: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY22 FY23 FY24 FY25 Revenue from Operations 11,533 10,518 7,231 7,188 Total Expenses 9,484 8,875 6,849 6,651 EBITDA 2,049 1,643 382 537 EBITDA Margins (%) 17.77% 15.62% 5.28% 7.47% Other Income 74 80 93 86 Depreciation 296 292 349 358 Fin
Slide 18: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet Particulars (INR Mn) FY23 FY24 FY25 Particulars (INR Mn) FY23 FY24 FY25 EQUITY 7,401 7,293 7,253 Non-Current Assets 7,682 8,352 8,269 a) Equity Share Capital 272 276 280 a) Property, Plant and Equipment 6,565 6,297 6,437 b) Other Equity 6,616 7,017 6,973 c) Righ
Slide 19: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY22 FY23 FY24 FY25 Revenue from Operations 9,484 9,116 6,772 7,188 Total Expenses 7,811 7,817 6,376 6,651 EBITDA 1,673 1,299 396 537 EBITDA Margins (%) 17.64% 14.25% 5.85% 7.47% Other Income 33 29 29 81 Depreciation 273 276 340 358 Finance
Slide 20: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet Particulars (INR Mn) FY23 FY24 FY25 Particulars (INR Mn) FY23 FY24 FY25 EQUITY 6,661 6,649 6,616 Non-Current Assets 7,424 7,818 7,750 a) Equity Share Capital 272 276 280 a) Property, Plant and Equipment 6,092 6,297 6,437 b) Other Equity 6,385 6,373 6,336 b) Right-
Slide 21: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 11,533 1,279 2,049 1,400 10,518 10,000 1,643 1,100 1,026 7,500 7,231 7,188 800 5,000 537 500 17.77% 15.62% 382 2,500 5.28% 200 11.09% 9.75% -34 7.47% -84 - -100 FY22 FY2
Slide 22: Capital Market Information
Capital Market Information Share Price up to 31st March, 2025 30% 10% -10% -30% -50% -70% Apr-24 May-24 Jun-24 Jul-24 Aug-24 Sep-24 Oct-24 Nov-24 Dec-24 Jan-25 Feb-25 Mar-25 Valiant Organics Sensex Price Data (As of 31st March, 2025) INR Shareholding pattern (As of 31st March, 2025) FII; 0.37% DII;
Slide 23: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all event
Slide 24: Thank You
THANK YOU Valiant Organics Limited | Q4-2025 23